Braveheart Bio, Inc. Common Stock

BRVENASDAQ • USD
19.49 USD
↘ 0.13 (0.66%)AT CLOSE (03:59 PM EST)
18.40
↘ 1.09 (5.61%)
POST MARKET (AS OF 07:30 PM EST)
Post Market
AS OF 07:30 PM EST
18.40
↘ 1.09 (5.61%)
🔴Market: CLOSED

BRVE is currently priced at $19.55. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Nov 16, 2026.

Open?$19.53
High?$20.21
Low?$18.71
Prev. Close?$19.62
Volume?725.4K
Avg. Volume?N/A
VWAP?$19.39
Bid / Ask
Bid?$16.88 × 100
Ask?$20.01 × 500
Spread?$3.13
Midpoint?$18.45
Valuation & Ratios
Market Cap?1.8B
Shares Out?N/A
Float?45.1M
Float %?50.1%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).
Employees
N/A
Market Cap
1.8B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2026-08-06
Address
ONE LETTERMAN DR.
SAN FRANCISCO, CA 94129
Phone: (415) 707-6312
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?11.42%High
Short Interest?5.2M
Days to Cover?19.6
Free Float45.1M
Avg Daily Volume262.6K
Settlement Date2026-10-30